News

Cresco Labs Reports Q2 2024 Financial Results

LOS ANGELES- Cresco Labs Inc. has released its financial results for the second quarter of 2024, showcasing significant improvements in profitability and maintaining strong market positions across several states. Key highlights from the report include: Revenue: $184 million Adjusted EBITDA: $54 million, reflecting a 33% year-over-year increase Adjusted EBITDA Margin: 29%, an 880 basis point ...

August 8th, 2024|Capital|
  • U.S. Cannabis Market, Medical Marijuana Market

Missouri Division of Cannabis Regulation Recalls Over 2,600 Products for Inadequate Testing

LOS ANGELES- The Missouri Division of Cannabis Regulation (DCR) announced a recall on Tuesday for 2,649 cannabis products sold by NGWMO, LLC to dispensary facilities. The recall was issued because the products did not undergo the required final stage testing. According to the DCR, the products, which include flower, pre-rolls, and kief sold under the ...

August 8th, 2024|Justice|

Aurora Cannabis Reports Q1 Fiscal 2025 Financial Results

LOS ANGELES- Aurora Cannabis has announced its financial results for the first quarter of fiscal 2025, ending June 30, 2024. The company reported positive free cash flow, increased revenue, and substantial growth in its global medical cannabis segment. Key Financial Highlights Aurora Cannabis achieved positive free cash flow of $6.5 million for the quarter. Total ...

August 7th, 2024|Capital|

DEA’s Proposed Rescheduling of Cannabis Sparks Public Response

LOS ANGELES- The Drug Enforcement Administration (DEA) has proposed rescheduling cannabis under federal drug law, moving it from Schedule I to Schedule III. This shift reflects changing perceptions about cannabis, which is currently classified alongside drugs deemed to have "no currently accepted medical use and a high potential for abuse," such as heroin and ecstasy. ...

August 7th, 2024|Justice|

Trulieve Reports Q2 2024 Financial Results

LOS ANGELES- Trulieve announced its financial results for the second quarter ending June 30, 2024. The results, reported in U.S. dollars and following U.S. Generally Accepted Accounting Principles (GAAP), reflect continued growth and operational expansion. Revenue and Sales Performance Trulieve achieved a revenue of $303 million, showing a 2% increase from the previous quarter and ...

August 7th, 2024|Business|

NYC Crackdown on Illegal Cannabis Shops Shutters 3,000, Creating Opportunities for Legal Retailers

LOS ANGELES- New York City has intensified its efforts to close nearly 3,000 unlicensed cannabis dispensaries, a move that could provide a boost for legal retailers struggling with high rents and intense competition. Since the state authorized the crackdown last month, hundreds of illegal shops have been shut down, with many more voluntarily closing to ...

August 6th, 2024|Business|

The Battle Over Recreational Cannabis Legalization Heats Up

LOS ANGELES- The debate around legalizing recreational cannabis continues to draw support and opposition from various societal factions. Central to this contentious issue is a push to amend state laws to allow adults aged 21 and over to legally possess and purchase cannabis. This article examines the latest developments in one state’s efforts toward this ...

August 6th, 2024|Insights|
  • Cannabis in Food and Beverage Market

Missouri Governor Signs Executive Order to Ban Intoxicating Hemp Product Sales

LOS ANGELES- Missouri Governor Mike Parson has signed an executive order banning the sale of intoxicating, hemp-derived products in the state, effective September 1. The order prohibits the sale of hemp-derived products containing delta-8 and delta-10 THC, hexahydrocannabinol (HHC), tetrahydrocannabinol (THC-O), tetrahydrocannabiphoral (THCP), and tetrahydrocannabivarin (THCV) unless sourced from an approved provider. The governor cited ...

August 6th, 2024|Justice|

NEWS: Ohio Dispensaries Set to Begin Recreational Cannabis Sales

CLEVELAND- Starting Tuesday, Ohioans aged 21 and over will have the opportunity to purchase recreational cannabis without needing a medical card. This marks a significant change in the state's cannabis regulations. The Ohio Department of Commerce Division of Cannabis Control is issuing its first set of dual-use Certificates of Operation (COO) to 98 dispensaries across ...

August 5th, 2024|Business|

Government Survey Data Shows Nearly 20 Percent Decline in Teen Cannabis Use Over Past Decade

LOS ANGELES- Government survey data released today by the US Department of Health and Human Services confirms that state-specific cannabis legalization laws have not negatively impacted teen cannabis use rates. The latest National Survey on Drug Use and Health (NSDUH) from the Substance Abuse Mental Health Services Administration (SAMHSA) reveals that teenagers are significantly less ...

August 5th, 2024|Insights|

Ohio to Launch Recreational Cannabis Sales 

LOS ANGELES- Ohio will commence recreational cannabis sales early next week, possibly as soon as Tuesday, August 6, following the issuance of the first necessary licenses on Monday. Jamie Crawford, Public Information Officer for Ohio’s Department of Commerce, stated, “We intend to issue the first set of non-medical licenses on Tuesday. There will be no ...

August 5th, 2024|Insights|

Week In Review: Ohio Comes On Line; Texas Cities Advance Cannabis Decriminalization Efforts; Tilray Expands in Portugal; Philippine Lawmakers Push for Medical Cannabis Legalization

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights #1 Texas Cities Advance Cannabis Decriminalization Efforts Amid Legal Challenges: Activists in several Texas ...

August 5th, 2024|Business, The Week in Review|

Incannex Healthcare Receives FDA Approval for Phase 2 Clinical Trial of Psilocybin Therapy

LOS ANGELES- Incannex Healthcare Inc. a clinical-stage pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to commence a Phase 2 clinical trial for its psilocybin pharmaceutical formulation, PSX-001, in combination with psychotherapy for patients with generalized anxiety disorder in the United States and the United Kingdom. The FDA completed its ...

August 5th, 2024|Psychedelics|

Ascend Wellness Stock Rises Amid Major Debt Refinancing Deal

LOS ANGELES- Ascend Wellness Holdings, Inc. saw its stock price increase by 2.9% on Friday, trading as high as $1.07 before closing at the same price. This trading activity represented a 301% increase in volume, with 48,219 shares changing hands, compared to the average daily volume of 12,015 shares. The company, a major player in ...

August 2nd, 2024|Insights|

Tilray Expands Medical Cannabis Portfolio in Portugal

LOS ANGELES- Tilray Brands, Inc.  has announced a new achievement in its European medical cannabis operations. The company received approval for its new product, Tilray Solução Oral THC10, in Portugal. This follows earlier approvals for Tilray Medical's whole flower THC 18 and another cannabis extract in the country. Denise Faltischek, Tilray's Chief Strategy Officer and ...

August 2nd, 2024|Capital|

Philippine Lawmakers Push for Medical Cannabis Legalization

LOS ANGELES- The Philippines is making another attempt to legalize medical cannabis, with the House of Representatives approving a new bill on Tuesday. The measure, passed by a vote of 177-9, seeks to establish a medical cannabis office under the Department of Health. This office would be responsible for formulating regulations regarding the medical use ...

August 2nd, 2024|Justice|

COMPASS Pathways Evaluates Prospects Despite Earnings Miss

LOS ANGELES- COMPASS Pathways  reported a quarterly loss of $0.55 per share on May 8th, missing analysts' expectations of a $0.52 loss. The company is forecasted to post a loss of $2 per share for the current and next fiscal years. Despite the earnings miss, COMPASS's stock rose by $0.52 to close at $7.46 on ...

August 1st, 2024|Capital|

Curaleaf Earnings Estimates Lowered

LOS ANGELES- Analysts at Atb Cap Markets have revised their Q2 2024 earnings estimates for Curaleaf Holdings, Inc. now forecasting a loss of $0.04 per share, down from a previous estimate of $0.03 per share. This adjustment follows the company's reported Q1 2024 earnings of $0.07 per share, which missed the consensus estimate of $0.06. ...

August 1st, 2024|Capital, Uncategorized|

Trulieve Contributes $5 Million to Florida Recreational Cannabis Campaign

LOS ANGELES- Trulieve, a medical cannabis company, has contributed an additional $5 million to support the campaign for legalizing recreational cannabis in Florida. This donation, made on July 15th, was directed to the Smart & Safe Florida political committee, which is spearheading the initiative for the November ballot. According to the state Division of Elections, ...

July 31st, 2024|Insights|

Aurora Cannabis Reports Quarterly Earnings

LOS ANGELES- Aurora Cannabis Inc. reported its quarterly earnings on Thursday, June 20th, surprising analysts with a positive earnings per share (EPS) of $0.11. This result significantly surpassed the consensus estimate of a $0.18 loss per share, indicating a $0.29 beat. Despite this earnings outperformance, Aurora continues to face challenges, including a negative return on ...

July 31st, 2024|Capital|

Texas Cities Advance Cannabis Decriminalization Efforts Amid Legal Challenges

LOS ANGELES-  Activists in several Texas cities are pushing for cannabis decriminalization, with measures set to appear on the November ballot in Lockhart, Dallas, and potentially Bastrop. These initiatives aim to reduce penalties for possession of cannabis, reflecting a broader trend in the state towards relaxing enforcement despite Texas' strict regulations. In Lockhart, the city ...

July 30th, 2024|Justice|

Tilray Brands Reports 26% Increase in Revenue for Fiscal 2024

LOS ANGELES- Tilray Brands announced a 26% increase in net revenue for the fiscal year ending May 31, 2024, reaching $789 million. This result surpassed Wall Street analysts' projections of $783 million. The company's growth was largely driven by its beverage-alcohol and cannabis segments. The beverage-alcohol sector showed significant growth, with net revenue increasing by ...

July 30th, 2024|Capital|

Ohio Cannabis Health & Business Summit 2024: Exploring the Future of Medical and Adult-Use Cannabis

CLEVELAND, Ohio – The Ohio Cannabis Health & Business Summit (OCHBS) is thrilled to announce its annual conference, scheduled for October 4-5, 2024, at the I-X Center in Cleveland, Ohio. Since its inception in 2019, OCHBS has been committed to supporting and growing the Ohio cannabis industry. As the state prepares to expand its program ...

July 29th, 2024|Business|

Verano Acquires Cannabist Company’s Assets in Virginia, Arizona for $105 Million

NEW YORK- Verano Holdings Corp., a Chicago-based cannabis operator, has reached an agreement to acquire the plant-touching operations of The Cannabist Co. in Arizona and Virginia. The acquisition, valued at $105 million in a mix of cash, stock, and promissory notes, will expand Verano's presence to 14 U.S. markets, according to a Monday announcement. In ...

July 29th, 2024|Capital|

Kamala Harris Emerges as Pro-Cannabis Advocate Amidst Potential Presidential Bid

LOS ANGELES- Vice President Kamala Harris, once opposed to cannabis legalization during her tenure as District Attorney of San Francisco, has now become a leading advocate for the cause. In April, she made history as the first U.S. vice president to publicly support cannabis legalization, emphasizing the need for reform in her statement, "We need ...

July 29th, 2024|Insights|
Go to Top